This invention relates to a process of the preparation of the novel
intermediate (S)-4-fluoromethyl-dihydro-furan-2-one of the formula
##STR00001## and with its use for the manufacture of
pyrido[2,1-a]isoquinoline derivatives of the formula ##STR00002## which
are useful for the treatment and/or prophylaxis of diseases which are
associated with DPP IV.